Learn More
Medchemexpress LLC Vernakalant (hydrochloride) | 748810-28-8 | MFCD09833303 | 99.3% | C20H32ClNO4 | 50 MG

Supplier: Medchemexpress LLC HY1418350MG
Vernakalant hydrochloride is a small molecule drug approved in 2010 for atrial fibrillation. It functions as a mixed voltage- and frequency-dependent Na+ and atria-preferred K+ channel blocker, targeting specific Kv1.5 channels.
- Potassium channel blocker
- Mixed voltage- and frequency-dependent Na+ channel blocker
- Soluble in DMSO and water
- Stable under recommended storage conditions
- Solid form, white to light yellow appearance
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.